AndroGel defendants try to bar FTC studies from trial; Hamburg to serve as IOM adviser;

@FiercePharma: AZ's Onglyza has most to lose at FDA safety confab, analysts say. Story | Follow @FiercePharma

@EricPFierce: Supply chain slip results in expired #Pfizer birth control pills being sold in Canada. More | Follow @EricPFierce

@CarlyHFierce: Mid-cap biotech beats most of the big dogs with 21.9% revenue growth. Article | Follow @CarlyHFierce

> AbbVie ($ABBV) and its fellow defendants asked a judge to bar the Federal Trade Commission from using studies about the pharmaceutical industry in an upcoming pay-for-delay trial over AndroGel. Report (reg. req.)

> Former FDA Commissioner Margaret Hamburg has joined the Institute of Medicine as a senior adviser focused on international matters. Report

> A Georgia federal judge ordered prosecutors to add details to an indictment accusing an accountant of insider trading related to a $1.9 billion Sanofi ($SNY) acquisition. Report (reg. req.)

> Pharmacy chain Walgreens Boots Alliance ($WBA) expanded its restructuring program with plans to close 200 U.S. stores. Report (sub. req.)

> Four Indian pharma companies saw their shares fall after Bank of America Merrill Lynch issued a downgrade. Report

Medical Device News

@FierceMedDev: France's Labco tiptoes closer to IPO. FierceDiagnostics article | Follow @FierceMedDev

@VarunSaxena2: ICYMI from FierceDiagnostics: Alere earns FDA clearance for rapid diagnostic of Strep A. News | Follow @VarunSaxena2

@EmilyWFierce: Roche nabs EU approval for Avastin for cervical cancer. Report from FiercePharma | Follow @EmilyWFierce

> Aethlon Medical eyes full marketing approval for Ebola biofiltration device. Story

> Synaptive's 'GPS for the brain' gets FDA green light. Article

Biotech News

@FierceBiotech: One of Shire's top blockbuster drug prospects flops in a key PhII study. News | Follow @FierceBiotech

@JohnCFierce: What bubble? Woodford boosts biotech fund max to $1.2B as investors crowd in. More | Follow @JohnCFierce

@DamianFierce: ICYMI: The thrilling conclusion to #FierceMadness and why I've had "One Shining Moment" stuck in my head all day. Story | Follow @DamianFierce

> Edge Therapeutics hauls in $72.5M for brain injury R&D. More

> Prothena files for follow-on offering to build $400M R&D war chest. News

CRO News

> WuXi gets a manufacturing subsidiary on the Chinese stock market. Report

> Parexel partners up for clinical trial education. News

> Catalent reaches into Australia with latest buyout. More

> PPD sets off in Japan with SNBL joint venture. Story

> AMRI shutters another plant with an eye on its bottom line. Article

Vaccines News

> GSK relocates vaccine R&D to Maryland with new global center. Story

> Sanofi teams up with VBI Vaccines to improve vaccine stability. News

> Duke University scores $20M from NIH to develop HIV vaccine. Report

> Sanofi 'flipping the model' for high-stakes dengue rollout. More

> Northwest Bio gets $40M more for controversial brain cancer vaccine. Article

Pharma Manufacturing News

> Report: Supply chain efficiency can boost both top- and bottom-line results. Story

> Cipla buying Brazilian distributor for beachhead there. News

> Expired Pfizer contraceptives recalled after supply chain fumble. Report

> Indonesia market expanding but local producers can't keep up. Article

> Chinese drugmaker to build $60M API plant. Story

Pharma Asia News

> Japan, S. Korea hospitals ink clinical pact on regenerative medicine. News

> China's Sihuan marks first U.S. patient enrollment of PhI oncology candidate. Item

> India drug price chief sacked as essential drug prices rise. Article

> U.S. unit of Glenmark settles Medicaid charges for $25M. Story

> Asian device market set to leap to $15B in 2017. Report

And Finally... After a measles outbreak in California, state lawmakers have advanced a bill eliminating parental waivers exempting kids from vaccination. Report (sub. req.)